FDC
Back to Balance Sheet
|
FDC Last 5 Year Total Non-Current Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Non-Current Liabilities | ₹812 Cr | ₹604 Cr | ₹469 Cr | ₹391 Cr | ₹300 Cr |
What is the latest Total Non-Current Liabilities ratio of FDC ?
| Year | Total Non-Current Liabilities |
|---|---|
| Mar2025 | ₹812 Cr |
| Mar2024 | ₹604 Cr |
| Mar2023 | ₹469 Cr |
| Mar2022 | ₹391 Cr |
| Mar2021 | ₹300 Cr |
How is Total Non-Current Liabilities of FDC Trending?
| Years | Total Non-Current Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹812 Cr | 34.38 | |
| Mar2024 | ₹604 Cr | 28.92 | |
| Mar2023 | ₹469 Cr | 19.81 | |
| Mar2022 | ₹391 Cr | 30.55 | |
| Mar2021 | ₹300 Cr | - | |
Compare Total Non-Current Liabilities of peers of FDC
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| FDC | ₹5,610.1 Cr | -3.9% | -16.7% | -27.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹455,394.0 Cr | -2.3% | -3.3% | 15.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹226,312.0 Cr | 0.3% | 16.3% | 44.3% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹190,678.0 Cr | 2.8% | -0.5% | 37.1% | Stock Analytics | |
| CIPLA | ₹114,392.0 Cr | -3.1% | -1.2% | -5.8% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹97,740.5 Cr | -2.9% | -3% | -3.3% | Stock Analytics | |
FDC Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| FDC | -3.9% |
-16.7% |
-27.3% |
| SENSEX | -1.4% |
-1% |
-4.6% |
You may also like the below Video Courses